Search results :

Amprenavir

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AE05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Hyperglycaemia uncommon, 41% - 58% x x x x x x
Hypertriglyceridaemia common, 40% - 56% x x x
Loose stools common, 32% - 60% x x x
Diarrhoea very common, 5% - 60% x x x x x x
Flatulence very common x
Inflammation very common x
Opportunistic infection very common x
Vomiting very common, 2% - 24% x x x x x x
Hypercholesterolaemia postmarketing — 9% - 15% x x x x x x
Paraesthesia 1% - 31% x x
Rash very common, 2% - 20% x x x x x
Affective disorder common, 4% - 13% x x x
Anorexia common x
Depressive disorder common x
Gastrointestinal disorder common x
Nausea very common, 4% - 7% x x x x x x
Tremor common x
Amylase increased common x
Abdominal discomfort common x
Hepatobiliary disease common x
Sleep disorder common x
Dyspeptic signs and symptoms common x
Fat redistribution common x x
Perioral paraesthesia common x
Taste disorders 1% - 8% x x
Headache very common, 2% - 4% x x x x x
Transaminases increased uncommon, common x
Fatigue very common, 1% - 2% x x x x x
Abdominal pain common, 0% - 2% x x x x x x
Hyperbilirubinaemia uncommon x
Angioedema postmarketing, uncommon x x x x
Cardiac disorder postmarketing x x x
Myocardial infarction postmarketing x x x
Nervous system disorder postmarketing, common x x x x
Stevens-Johnson syndrome rare x x x
Malnutrition postmarketing x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x
Nephrolithiasis postmarketing x x x
Paraesthesia oral postmarketing x x x
Mental disorder x
Connective tissue disorder x
Diabetes mellitus x x
Hepatitis B x
Hypertrophy of breast x
Insulin resistance x
Lipodystrophy x
Myositis x
Neutropenia x x
Pruritus x x x x x x
Rhabdomyolysis x
Creatine phosphokinase increased x
Liver function test abnormal x
Aspartate aminotransferase increased x x x
Alanine aminotransferase increased x x x
Myalgia x
Discomfort x
Gastrointestinal symptom NOS x
Buffalo hump x x x
Abdominal symptom x
Hyperlactacidaemia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

AMPRENAVIR

Side effects:20
Source:FDA Structured Product Label

AMPRENAVIR

Side effects:20
Source:FDA Structured Product Label

AMPRENAVIR

Side effects:21
Source:FDA Structured Product Label

AMPRENAVIR / AGENERASE

Side effects:16
Source:FDA

amprenavir / Agenerase

Side effects:21
Source:FDA

amprenavir / amprenavir

Side effects:48
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label